title: Neonatal Torulopsis glabrata fungemia.
abstract: Torulopsis glabrata is a yeastlike fungus that has recently become recognized as an important opportunistic pathogen. Only four cases of T glabrata infection in neonates have been reported. We report two cases of fungemia caused by this organism in premature infants. Both patients were treated with amphotericin B and survived the fungemia, but one patient later died of bacterial sepsis. Both patients had been treated with surfactant, artificial ventilation, intravascular catheters (arterial and venous), broad spectrum antibiotics, and hyperalimentation, which appear to be risk factors for T glabrata fungemia. A review of the literature indicates that T glabrata is susceptible to amphotericin B and 5-fluorocytosine and is resistant to fluconazole. In addition, it is less susceptible to ketoconazole, clotrimazole, and itraconazole than is Candida albicans. We recommend that T glabrata infections be treated initially by reducing iatrogenic risk factors and beginning amphotericin B therapy. If necessary, 5-fluorocytosine should be added to the drug regimen.
authors.affiliation: Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga. 30303, USA.
authors.forename: J D
authors.initials: JD
authors.lastname: Reich
authors.forename: K
authors.initials: K
authors.lastname: Huddleston
authors.forename: D
authors.initials: D
authors.lastname: Jorgensen
authors.forename: F E
authors.initials: FE
authors.lastname: Berkowitz
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002175:Candida / Q000302:isolation & purification*; D002177:Candidiasis / Q000188:drug therapy*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D012121:Respiration, Artificial
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B